Compare GRANULES INDIA with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA CIPLA GRANULES INDIA/
CIPLA
 
P/E (TTM) x 16.0 30.5 52.5% View Chart
P/BV x 3.1 4.3 72.0% View Chart
Dividend Yield % 0.6 0.5 108.9%  

Financials

 GRANULES INDIA   CIPLA
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
CIPLA
Mar-21
GRANULES INDIA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs438879 49.9%   
Low Rs138411 33.6%   
Sales per share (Unadj.) Rs130.7237.6 55.0%  
Earnings per share (Unadj.) Rs22.229.8 74.5%  
Cash flow per share (Unadj.) Rs28.343.0 65.8%  
Dividends per share (Unadj.) Rs1.505.00 30.0%  
Avg Dividend yield %0.50.8 67.1%  
Book value per share (Unadj.) Rs86.8226.7 38.3%  
Shares outstanding (eoy) m247.67806.46 30.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.22.7 81.2%   
Avg P/E ratio x13.021.6 60.0%  
P/CF ratio (eoy) x10.215.0 67.9%  
Price / Book Value ratio x3.32.8 116.7%  
Dividend payout %6.816.8 40.3%   
Avg Mkt Cap Rs m71,337519,826 13.7%   
No. of employees `000NANA-   
Total wages/salary Rs m3,24332,518 10.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,375191,596 16.9%  
Other income Rs m2692,698 10.0%   
Total revenues Rs m32,644194,294 16.8%   
Gross profit Rs m8,55242,487 20.1%  
Depreciation Rs m1,51510,677 14.2%   
Interest Rs m2631,607 16.4%   
Profit before tax Rs m7,04432,901 21.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5498,888 17.4%   
Profit after tax Rs m5,49524,013 22.9%  
Gross profit margin %26.422.2 119.1%  
Effective tax rate %22.027.0 81.4%   
Net profit margin %17.012.5 135.4%  
BALANCE SHEET DATA
Current assets Rs m19,970132,095 15.1%   
Current liabilities Rs m11,73145,916 25.5%   
Net working cap to sales %25.445.0 56.6%  
Current ratio x1.72.9 59.2%  
Inventory Days Days1668 24.1%  
Debtors Days Days8637 13,146.1%  
Net fixed assets Rs m17,157116,277 14.8%   
Share capital Rs m2481,613 15.4%   
"Free" reserves Rs m21,262181,232 11.7%   
Net worth Rs m21,510182,844 11.8%   
Long term debt Rs m3,41112,028 28.4%   
Total assets Rs m37,127248,372 14.9%  
Interest coverage x27.821.5 129.5%   
Debt to equity ratio x0.20.1 241.1%  
Sales to assets ratio x0.90.8 113.0%   
Return on assets %15.510.3 150.3%  
Return on equity %25.513.1 194.5%  
Return on capital %29.317.7 165.6%  
Exports to sales %81.931.3 261.9%   
Imports to sales %26.810.9 246.0%   
Exports (fob) Rs m26,52859,951 44.2%   
Imports (cif) Rs m8,69120,911 41.6%   
Fx inflow Rs m26,52868,051 39.0%   
Fx outflow Rs m8,69120,911 41.6%   
Net fx Rs m17,83747,140 37.8%   
CASH FLOW
From Operations Rs m4,32537,552 11.5%  
From Investments Rs m-2,771-23,872 11.6%  
From Financial Activity Rs m-2,993-13,299 22.5%  
Net Cashflow Rs m-1,441509 -283.0%  

Share Holding

Indian Promoters % 41.6 13.5 308.6%  
Foreign collaborators % 0.4 20.1 1.7%  
Indian inst/Mut Fund % 27.2 48.6 55.9%  
FIIs % 23.2 26.6 87.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 66.4 87.4%  
Shareholders   210,785 418,584 50.4%  
Pledged promoter(s) holding % 7.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    



Today's Market

Sensex Rallies 632 Points, Nifty Ends Above 16,350; Banking & IT Stocks Witness Buying(Closing)

Indian share markets rose today as easing bets about aggressive interest rate hikes by central banks lifted sentiment.

Related Views on News

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


May 27, 2022 03:30 PM

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA 8-QTR ANALYSIS

COMPARE GRANULES INDIA WITH

MARKET STATS